Press Releases

Biocon Biologics / News – Posts / Press Releases

Biocon Q4FY23 Revenue at Rs 3,929 Cr, Up 59%; Biosimilars Up 114%; Research Services Up 31%

Tue, 23-May-2023
Posted by: Biocon Biologics

Biocon Biologics’ New mAbs Facility Receives EU GMP Certification for bBevacizumab

Fri, 28-Apr-2023
Posted by: Biocon Biologics

Serum & Biocon Biologics Agree to Restructure Equity Investment

Tue, 25-Apr-2023
Posted by: Biocon Biologics

Biocon Awarded a Silver Medal by EcoVadis for its Sustainability Accomplishments

Mon, 03-Apr-2023
Posted by: Biocon Biologics

Biocon Biologics Wins the ‘ABEA : Bioprocessing Excellence in South Asia’ Award

Tue, 28-Mar-2023
Posted by: Biocon Biologics

Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18%

Thu, 09-Mar-2023
Posted by: Biocon Biologics

Biocon Biologics Recognized as a Company with Great Managers; Two Managers conferred with individual ‘Great Managers Award 2022’

Thu, 22-Dec-2022
Posted by: Biocon Biologics

Shreehas Tambe Appointed as Managing Director & CEO of Biocon Biologics Limited

Mon, 05-Dec-2022
Posted by: Biocon Biologics

Biocon Biologics Completes Acquisition of Viatris’ Global Biosimilars Business

Tue, 29-Nov-2022
Posted by: Biocon Biologics

Biocon Q2FY23 Revenue at Rs 2,384 Cr, Up 23%; Core EBITDA at Rs 816 Cr, Up 34% Gross R&D Spend at Rs 252 Crore, Up 52%

Tue, 15-Nov-2022
Posted by: Biocon Biologics

1
2
3
…
16